GGrantIndex
Sort

261,768 grants matching gene therapy

Comparative Mechanisms of Cancer Chemoprevention

$1,392,370
Roderick H Dashwood · Texas A&M University Health Science Ctr · P01 · FY2014 · CA

PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study

$1,392,367
Christine M Albert · Brigham And Women'S Hospital · R01 · FY2008 · HL

Perturbation of the treatment resistant depression connectome by fast-acting therapies

$1,392,362
Katherine L Narr · University Of California Los Angeles · U01 · FY2016 · MH

Studies Of Central Nervous System Functional Anatomy

$1,392,327
Miles A. Herkenham · National Institute Of Mental Health · ZIA · FY2015 · MH

Development of EP2 Receptor Antagonist to Treat Alzheimer's Disease

$1,392,306
Thota Ganesh · Emory University · U01 · FY2025 · AG

Center of Research Translation on Osteoporosis Bone Anabolic Therapies

$1,392,115
Marc Nathan Wein · Massachusetts General Hospital · P50 · FY2025 · AR

Targeted Prevention for Non-Melanoma Skin Cancer

$1,392,093
Clara Curiel-Lewandrowski · University Of Arizona · P01 · FY2019 · CA

Pathogenesis and treatment of autoinflammatory diseases i.e.NOMID,DIRA,CANDLE, SAVI and others

$1,391,894
Raphaela Goldbach-Mansky · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2015 · AR

Rational approaches to melanoma therapy

$1,391,843
Meenhard Herlyn · Wistar Institute · U54 · FY2021 · CA

Structure-Function of Opioid Receptors

$1,391,835
Raymond C Stevens · University Of Southern California · P01 · FY2017 · DA

Role of Inducible Bronchus Associated Lymphoid Tissue in Latent Tuberculosis

$1,391,820
Shabaana A. Khader · Washington University · R01 · FY2021 · AI

Customized stem cells for clinical application in blood disorders

$1,391,696
George Q Daley · Boston Children'S Hospital · R24 · FY2015 · DK

Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Center

$1,391,658
Richard J Samulski · Univ Of North Carolina Chapel Hill · U54 · FY2012 · AR

Normal And Pathologic Mechanisms Of Inflammation, Innate And Acquired Immunity

$1,391,554
Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2011 · DE

Development of Akt Inhibitors

$1,391,366
Phillip A. Dennis · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Muscular Dystrophy Cooperative Research Center

$1,391,238
University Of Washington · U54 · FY2003 · HD

Human pluripotent stem cells

$1,391,123
Pamela Robey · National Institute Of Neurological Disorders And Stroke · ZIC · FY2025 · NS

Molecular and cellular mechanisms of the FVIII immune response

$1,390,984
Valder R Arruda · Children'S Hosp Of Philadelphia · U54 · FY2020 · HL

Development of an UNC13A antisense oligonucleotide treatment for ALS and FTD

$1,390,906
Peter Sazani · Acurastem, Inc. · R44 · FY2023 · NS

Improving the Outcome of Patients with Chronic Myeloid Leukemia Through Medi

$1,390,873
Jorge E Cortes · University Of Tx Md Anderson Can Ctr · P01 · FY2010 · CA

A democratized platform for mapping the spatial epigenome in tissue

$1,390,826
Jeffrey Sabina · Atlasxomics Inc. · R44 · FY2023 · CA

Clinical Features and Neuropathological Basis of Sleep Wake Behavior in Alzheimer's and PSP

$1,390,787
Thomas C Neylan · University Of California, San Francisco · R01 · FY2025 · AG

Next Generation GPC2-CARs for Medulloblastoma

$1,390,720
Crystal Mackall · Stanford University · UG3 · FY2024 · CA

Next Generation GPC2-CARs for Medulloblastoma

$1,390,720
Crystal Mackall · Stanford University · UG3 · FY2025 · CA

Therapeutic Vaccination for HIV Using VEE Vectors

$1,390,608
University Of North Carolina Chapel Hill · P01 · FY2002 · AI